APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transmembrane Protein

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Transmembrane Protein Market Outlook and Growth Opportunities 2026

Report ID 173370180410 April 2026Not stated

Choose your research edition.

Industry ResearchTransmembrane Protein Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Transmembrane Protein Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Transmembrane Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transmembrane Protein Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Transmembrane Protein Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Transmembrane Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Transmembrane Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transmembrane Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transmembrane Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Transmembrane Protein market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Transmembrane Protein market include Sino Biological, Kactus Biosystems, Dima Biotech, Detai Bioengineering, Cusabio, ACROBiosystems and Abiocenter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transmembrane Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transmembrane Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transmembrane Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transmembrane Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Transmembrane Protein Segment by Company

Sino Biological

Kactus Biosystems

Dima Biotech

Detai Bioengineering

Cusabio

ACROBiosystems

Abiocenter

Transmembrane Protein Segment by Type

Seven Transmembrane Proteins

Tetraspanin

Pentaspanin

Others

Transmembrane Protein Segment by Application

Cell Experiment

Immunoassay

CAR Positive Test

Transmembrane Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transmembrane Protein status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transmembrane Protein market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transmembrane Protein significant trends, drivers, influence factors in global and regions.

6. To analyze Transmembrane Protein competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transmembrane Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transmembrane Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transmembrane Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transmembrane Protein market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transmembrane Protein industry.

Chapter 3: Detailed analysis of Transmembrane Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transmembrane Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transmembrane Protein in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transmembrane Protein Industry Trends Table 2. Transmembrane Protein Industry Drivers Table 3. Transmembrane Protein Industry Opportunities and Challenges Table 4. Transmembrane Protein Industry Restraints Table 5. Global Transmembrane Protein Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transmembrane Protein Revenue Share by Company (2021-2026) Table 7. Global Transmembrane Protein Sales Volume by Company (t) & (2021-2026) Table 8. Global Transmembrane Protein Sales Volume Share by Company (2021-2026) Table 9. Global Transmembrane Protein Average Price (USD/t) of Company (2021-2026) Table 10. Global Transmembrane Protein Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transmembrane Protein Key Company Manufacturing Base & Headquarters Table 12. Global Transmembrane Protein Company, Product Type & Application Table 13. Global Transmembrane Protein Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transmembrane Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Seven Transmembrane Proteins Table 18. Significant Companies of Tetraspanin Table 19. Significant Companies of Pentaspanin Table 20. Significant Companies of Others Table 21. Global Transmembrane Protein Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 22. Global Transmembrane Protein Sales Volume by Type (2021-2026) & (t) Table 23. Global Transmembrane Protein Sales Volume by Type (2027-2032) & (t) Table 24. Global Transmembrane Protein Sales Volume Share by Type (2021-2026) Table 25. Global Transmembrane Protein Sales Volume Share by Type (2027-2032) Table 26. Global Transmembrane Protein Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Transmembrane Protein Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Transmembrane Protein Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Transmembrane Protein Sales Value Share by Type (2021-2026) Table 30. Global Transmembrane Protein Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Cell Experiment Table 32. Significant Companies of Immunoassay Table 33. Significant Companies of CAR Positive Test Table 34. Global Transmembrane Protein Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Transmembrane Protein Sales Volume by Application (2021-2026) & (t) Table 36. Global Transmembrane Protein Sales Volume by Application (2027-2032) & (t) Table 37. Global Transmembrane Protein Sales Volume Share by Application (2021-2026) Table 38. Global Transmembrane Protein Sales Volume Share by Application (2027-2032) Table 39. Global Transmembrane Protein Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Transmembrane Protein Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Transmembrane Protein Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Transmembrane Protein Sales Value Share by Application (2021-2026) Table 43. Global Transmembrane Protein Sales Value Share by Application (2027-2032) Table 44. Global Transmembrane Protein Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Transmembrane Protein Sales by Region (2021-2026) & (t) Table 46. Global Transmembrane Protein Sales Market Share by Region (2021-2026) Table 47. Global Transmembrane Protein Sales by Region (2027-2032) & (t) Table 48. Global Transmembrane Protein Sales Market Share by Region (2027-2032) Table 49. Global Transmembrane Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Transmembrane Protein Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Transmembrane Protein Sales Value Share by Region (2021-2026) Table 52. Global Transmembrane Protein Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Transmembrane Protein Sales Value Share by Region (2027-2032) Table 54. Global Transmembrane Protein Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Transmembrane Protein Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Transmembrane Protein Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Transmembrane Protein Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Transmembrane Protein Sales by Country (2021-2026) & (t) Table 59. Global Transmembrane Protein Sales Market Share by Country (2021-2026) Table 60. Global Transmembrane Protein Sales by Country (2027-2032) & (t) Table 61. Global Transmembrane Protein Sales Market Share by Country (2027-2032) Table 62. Global Transmembrane Protein Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Transmembrane Protein Sales Value Market Share by Country (2021-2026) Table 64. Global Transmembrane Protein Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Transmembrane Protein Sales Value Market Share by Country (2027-2032) Table 66. Sino Biological Company Information Table 67. Sino Biological Business Overview Table 68. Sino Biological Transmembrane Protein Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. Sino Biological Transmembrane Protein Product Portfolio Table 70. Sino Biological Recent Development Table 71. Kactus Biosystems Company Information Table 72. Kactus Biosystems Business Overview Table 73. Kactus Biosystems Transmembrane Protein Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Kactus Biosystems Transmembrane Protein Product Portfolio Table 75. Kactus Biosystems Recent Development Table 76. Dima Biotech Company Information Table 77. Dima Biotech Business Overview Table 78. Dima Biotech Transmembrane Protein Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Dima Biotech Transmembrane Protein Product Portfolio Table 80. Dima Biotech Recent Development Table 81. Detai Bioengineering Company Information Table 82. Detai Bioengineering Business Overview Table 83. Detai Bioengineering Transmembrane Protein Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Detai Bioengineering Transmembrane Protein Product Portfolio Table 85. Detai Bioengineering Recent Development Table 86. Cusabio Company Information Table 87. Cusabio Business Overview Table 88. Cusabio Transmembrane Protein Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Cusabio Transmembrane Protein Product Portfolio Table 90. Cusabio Recent Development Table 91. ACROBiosystems Company Information Table 92. ACROBiosystems Business Overview Table 93. ACROBiosystems Transmembrane Protein Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. ACROBiosystems Transmembrane Protein Product Portfolio Table 95. ACROBiosystems Recent Development Table 96. Abiocenter Company Information Table 97. Abiocenter Business Overview Table 98. Abiocenter Transmembrane Protein Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Abiocenter Transmembrane Protein Product Portfolio Table 100. Abiocenter Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Transmembrane Protein Distributors List Table 104. Transmembrane Protein Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Transmembrane Protein Product Image Figure 2. Global Transmembrane Protein Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transmembrane Protein Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transmembrane Protein Sales (2021-2032) & (t) Figure 5. Global Transmembrane Protein Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Transmembrane Protein Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Seven Transmembrane Proteins Image Figure 10. Tetraspanin Image Figure 11. Pentaspanin Image Figure 12. Others Image Figure 13. Global Transmembrane Protein Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Transmembrane Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Transmembrane Protein Sales Volume Share by Type (2021-2032) Figure 16. Global Transmembrane Protein Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Transmembrane Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Transmembrane Protein Sales Value Share by Type (2021-2032) Figure 19. Cell Experiment Image Figure 20. Immunoassay Image Figure 21. CAR Positive Test Image Figure 22. Global Transmembrane Protein Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Transmembrane Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Transmembrane Protein Sales Volume Share by Application (2021-2032) Figure 25. Global Transmembrane Protein Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Transmembrane Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Transmembrane Protein Sales Value Share by Application (2021-2032) Figure 28. Global Transmembrane Protein Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Transmembrane Protein Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Transmembrane Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Transmembrane Protein Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Transmembrane Protein Sales Value (2021-2032) & (US$ Million) Figure 33. North America Transmembrane Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Transmembrane Protein Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Transmembrane Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Transmembrane Protein Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Transmembrane Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Transmembrane Protein Sales Value (2021-2032) & (US$ Million) Figure 39. South America Transmembrane Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Transmembrane Protein Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Transmembrane Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Transmembrane Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Transmembrane Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Transmembrane Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Transmembrane Protein Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Transmembrane Protein Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Seven Transmembrane Proteins
  • Tetraspanin
  • Pentaspanin
  • Others
Applications
  • Cell Experiment
  • Immunoassay
  • CAR Positive Test
Companies covered
  • Sino Biological
  • Kactus Biosystems
  • Dima Biotech
  • Detai Bioengineering
  • Cusabio
  • ACROBiosystems
  • Abiocenter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transmembrane Protein Sales Value (2021-2032)
  4. 1.2.2 Global Transmembrane Protein Sales Volume (2021-2032)
  5. 1.2.3 Global Transmembrane Protein Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transmembrane Protein Market Dynamics
  1. 2.1 Transmembrane Protein Industry Trends
  2. 2.2 Transmembrane Protein Industry Drivers
  3. 2.3 Transmembrane Protein Industry Opportunities and Challenges
  4. 2.4 Transmembrane Protein Industry Restraints
3 Transmembrane Protein Market by Company
  1. 3.1 Global Transmembrane Protein Company Revenue Ranking in 2025
  2. 3.2 Global Transmembrane Protein Revenue by Company (2021-2026)
  3. 3.3 Global Transmembrane Protein Sales Volume by Company (2021-2026)
  4. 3.4 Global Transmembrane Protein Average Price by Company (2021-2026)
  5. 3.5 Global Transmembrane Protein Company Ranking (2024-2026)
  6. 3.6 Global Transmembrane Protein Company Manufacturing Base and Headquarters
  7. 3.7 Global Transmembrane Protein Company Product Type and Application
  8. 3.8 Global Transmembrane Protein Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transmembrane Protein Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transmembrane Protein Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transmembrane Protein Market by Type
  1. 4.1 Transmembrane Protein Type Introduction
  2. 4.1.1 Seven Transmembrane Proteins
  3. 4.1.2 Tetraspanin
  4. 4.1.3 Pentaspanin
  5. 4.1.4 Others
  6. 4.2 Global Transmembrane Protein Sales Volume by Type
  7. 4.2.1 Global Transmembrane Protein Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Transmembrane Protein Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Transmembrane Protein Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Transmembrane Protein Sales Value by Type
  11. 4.3.1 Global Transmembrane Protein Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Transmembrane Protein Sales Value by Type (2021-2032)
  13. 4.3.3 Global Transmembrane Protein Sales Value Share by Type (2021-2032)
5 Transmembrane Protein Market by Application
  1. 5.1 Transmembrane Protein Application Introduction
  2. 5.1.1 Cell Experiment
  3. 5.1.2 Immunoassay
  4. 5.1.3 CAR Positive Test
  5. 5.2 Global Transmembrane Protein Sales Volume by Application
  6. 5.2.1 Global Transmembrane Protein Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transmembrane Protein Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Transmembrane Protein Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Transmembrane Protein Sales Value by Application
  10. 5.3.1 Global Transmembrane Protein Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Transmembrane Protein Sales Value by Application (2021-2032)
  12. 5.3.3 Global Transmembrane Protein Sales Value Share by Application (2021-2032)
6 Transmembrane Protein Regional Sales and Value Analysis
  1. 6.1 Global Transmembrane Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transmembrane Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Transmembrane Protein Sales by Region: 2021-2026
  4. 6.2.2 Global Transmembrane Protein Sales by Region (2027-2032)
  5. 6.3 Global Transmembrane Protein Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transmembrane Protein Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transmembrane Protein Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transmembrane Protein Sales Value by Region (2027-2032)
  9. 6.5 Global Transmembrane Protein Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transmembrane Protein Sales Value (2021-2032)
  12. 6.6.2 North America Transmembrane Protein Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transmembrane Protein Sales Value (2021-2032)
  15. 6.7.2 Europe Transmembrane Protein Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transmembrane Protein Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transmembrane Protein Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transmembrane Protein Sales Value (2021-2032)
  21. 6.9.2 South America Transmembrane Protein Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transmembrane Protein Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transmembrane Protein Sales Value Share by Country, 2025 VS 2032
7 Transmembrane Protein Country-level Sales and Value Analysis
  1. 7.1 Global Transmembrane Protein Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transmembrane Protein Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transmembrane Protein Sales by Country (2021-2032)
  4. 7.3.1 Global Transmembrane Protein Sales by Country (2021-2026)
  5. 7.3.2 Global Transmembrane Protein Sales by Country (2027-2032)
  6. 7.4 Global Transmembrane Protein Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transmembrane Protein Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transmembrane Protein Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transmembrane Protein Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transmembrane Protein Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transmembrane Protein Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transmembrane Protein Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transmembrane Protein Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transmembrane Protein Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transmembrane Protein Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transmembrane Protein Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transmembrane Protein Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transmembrane Protein Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transmembrane Protein Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transmembrane Protein Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transmembrane Protein Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transmembrane Protein Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transmembrane Protein Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transmembrane Protein Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transmembrane Protein Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transmembrane Protein Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transmembrane Protein Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transmembrane Protein Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transmembrane Protein Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transmembrane Protein Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transmembrane Protein Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transmembrane Protein Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transmembrane Protein Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transmembrane Protein Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transmembrane Protein Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transmembrane Protein Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transmembrane Protein Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transmembrane Protein Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sino Biological
  2. 8.1.1 Sino Biological Company Information
  3. 8.1.2 Sino Biological Business Overview
  4. 8.1.3 Sino Biological Transmembrane Protein Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sino Biological Transmembrane Protein Product Portfolio
  6. 8.1.5 Sino Biological Recent Developments
  7. 8.2 Kactus Biosystems
  8. 8.2.1 Kactus Biosystems Company Information
  9. 8.2.2 Kactus Biosystems Business Overview
  10. 8.2.3 Kactus Biosystems Transmembrane Protein Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kactus Biosystems Transmembrane Protein Product Portfolio
  12. 8.2.5 Kactus Biosystems Recent Developments
  13. 8.3 Dima Biotech
  14. 8.3.1 Dima Biotech Company Information
  15. 8.3.2 Dima Biotech Business Overview
  16. 8.3.3 Dima Biotech Transmembrane Protein Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dima Biotech Transmembrane Protein Product Portfolio
  18. 8.3.5 Dima Biotech Recent Developments
  19. 8.4 Detai Bioengineering
  20. 8.4.1 Detai Bioengineering Company Information
  21. 8.4.2 Detai Bioengineering Business Overview
  22. 8.4.3 Detai Bioengineering Transmembrane Protein Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Detai Bioengineering Transmembrane Protein Product Portfolio
  24. 8.4.5 Detai Bioengineering Recent Developments
  25. 8.5 Cusabio
  26. 8.5.1 Cusabio Company Information
  27. 8.5.2 Cusabio Business Overview
  28. 8.5.3 Cusabio Transmembrane Protein Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cusabio Transmembrane Protein Product Portfolio
  30. 8.5.5 Cusabio Recent Developments
  31. 8.6 ACROBiosystems
  32. 8.6.1 ACROBiosystems Company Information
  33. 8.6.2 ACROBiosystems Business Overview
  34. 8.6.3 ACROBiosystems Transmembrane Protein Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 ACROBiosystems Transmembrane Protein Product Portfolio
  36. 8.6.5 ACROBiosystems Recent Developments
  37. 8.7 Abiocenter
  38. 8.7.1 Abiocenter Company Information
  39. 8.7.2 Abiocenter Business Overview
  40. 8.7.3 Abiocenter Transmembrane Protein Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abiocenter Transmembrane Protein Product Portfolio
  42. 8.7.5 Abiocenter Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transmembrane Protein Value Chain Analysis
  2. 9.1.1 Transmembrane Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transmembrane Protein Sales Mode & Process
  6. 9.2 Transmembrane Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transmembrane Protein Distributors
  9. 9.2.3 Transmembrane Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst